In vivo apoptosis imaging agents and strategies

Ming Zhao*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations


The noninvasive detection of apoptosis, or programmed cell death, is an important biomarker for the severity/progression of diseases and the efficacy of anticancer therapies. In the past decade a rapid expansion in the number of apoptosis imaging agents and techniques offers an increasingly wide selection of approaches for the assessment of apoptosis in vivo. The goal of this review is to provide a general account of existing and emerging apoptosis imaging techniques based on their modes of actions; and to critically discuss the major advantages and obstacles facing the field of apoptosis imaging. In conclusion, tremendous progress has been made in applying the concept of apoptosis imaging toward diagnostic needs. However, for imaging strategies involving exogenous agents, we must recognize the intrinsic distinction between probe density and target density, and appreciate the complexity of apoptosis imaging within the context of probe behaviors in the target tissue. For non-pharmaceutical imaging strategies, there is a continued drive to improve the specificity and applicability of these endogenous markers. Overall, what remains to be addressed, and is critical to clinical translation, is the noninvasive quantification, in addition to detection, of apoptosis in vivo.

Original languageEnglish (US)
Pages (from-to)1018-1023
Number of pages6
JournalAnti-cancer agents in medicinal chemistry
Issue number9
StatePublished - 2009


  • Apoptosis
  • Imaging
  • Probe

ASJC Scopus subject areas

  • Molecular Medicine
  • Cancer Research
  • Pharmacology


Dive into the research topics of 'In vivo apoptosis imaging agents and strategies'. Together they form a unique fingerprint.

Cite this